Document is current
Any future updates will be listed below
-
Authors
Saito, Tomoyuki https://orcid.org/0000-0003-3832-4230
Ohmura, Hirotoshi
Nojiri, Shuko
Daida, Hiroyuki
-
Funding
Funding for this research was provided by:
Waksman Foundation of Japan
MSD K.K.
Daiichi-Sankyo
Ono Pharmaceutical
Kyowa Hakko Kirin
- License Information
-
More Information
Article History
Received: 1 March 2020
Accepted: 11 May 2020
First Online: 4 June 2020
Ethics approval and consent to participate
: All procedures performed in this study, including human participants, complied with the ethical standards of the Institutional Research Committee (Juntendo Clinical Research and Testing Center of Juntendo University Hospital) and the 1964 Declaration of Helsinki and subsequent amendments or equivalent. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Hirotoshi Ohmuara has received lecture fees from Takeda Pharmaceutical Co., MSD K.K., AstraZeneca K.K., and Shionogi & Co. Ltd. and research funds from Pfizer Co., MSD K.K., and Takeda Pharmaceutical Co. Ltd. Hiroyuki Daida has received lecture fees from AstraZeneca K.K., MSD K.K., Kowa Pharmaceutical Company Ltd., Sanofi-Aventis K.K., GlaxoSmithKline K.K., Shionogi & Co. Ltd., Daiichi-Sankyo Company, Limited, Takeda Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corp., Pfizer Co. Ltd., and Astellas Pharma Inc. and research funds from Takeda Pharmaceutical Co. Ltd., Bristol-Myers Squibb Company, Nippon Boehringer Ingelheim Co. Ltd., Astellas Pharma Inc., Novartis Pharma K.K., MSD K.K., Sanofi-Aventis K.K., Otsuka Pharmaceutical Co. Ltd., Dainippon Sumitomo Pharma Co. Ltd., Pfizer Co. Ltd., Kowa Pharmaceutical Company Ltd., Shionogi & Co. Ltd., AstraZeneca K.K., Teijin Limited, and Morinaga Milk Industry Co. Ltd. Tomoyuki Saito and Shuko Nojiri have nothing to declare.
